nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—Infection—Methylprednisolone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Duloxetine—Shock—Triamcinolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Duloxetine—Insomnia—Prednisolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Duloxetine—Alopecia—Prednisone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Duloxetine—Shock—Methylprednisolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Duloxetine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Epistaxis—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Mental disorder—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Duloxetine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Duloxetine—Erythema—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Duloxetine—Malnutrition—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Duloxetine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Duloxetine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Duloxetine—Convulsion—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Duloxetine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Duloxetine—Hypertension—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Duloxetine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Duloxetine—Myalgia—Betamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Duloxetine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Duloxetine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Duloxetine—Anxiety—Betamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Duloxetine—Discomfort—Betamethasone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Duloxetine—Discomfort—Dexamethasone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Duloxetine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Duloxetine—Pain—Prednisolone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Duloxetine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Duloxetine—Hepatitis—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Duloxetine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Duloxetine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Duloxetine—Vision blurred—Prednisone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Oedema—Betamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Oedema—Dexamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Duloxetine—Insomnia—Triamcinolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Duloxetine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Duloxetine—Infection—Dexamethasone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Duloxetine—Infection—Betamethasone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Duloxetine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Visual impairment—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Anaemia—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Shock—Betamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Shock—Dexamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Duloxetine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Agitation—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Angioedema—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Duloxetine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Duloxetine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Duloxetine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Duloxetine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Duloxetine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Duloxetine—Malaise—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Duloxetine—Vertigo—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Duloxetine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Duloxetine—Syncope—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Duloxetine—Tinnitus—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Duloxetine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Duloxetine—Anorexia—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Duloxetine—Urticaria—Prednisolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Duloxetine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Duloxetine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Duloxetine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Duloxetine—Pain—Triamcinolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Duloxetine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Duloxetine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Duloxetine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Duloxetine—Convulsion—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Duloxetine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Duloxetine—Hypertension—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Duloxetine—Chills—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Duloxetine—Myalgia—Prednisone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Duloxetine—Arthralgia—Prednisone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Duloxetine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Duloxetine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Duloxetine—Anxiety—Prednisone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Duloxetine—Alopecia—Methotrexate—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Duloxetine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000999	0.000999	CcSEcCtD
Duloxetine—Insomnia—Betamethasone—ankylosing spondylitis	0.000999	0.000999	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000997	0.000997	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000994	0.000994	CcSEcCtD
Duloxetine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Duloxetine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Duloxetine—Discomfort—Prednisone—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Duloxetine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Duloxetine—Erythema—Methotrexate—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Duloxetine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000976	0.000976	CcSEcCtD
Duloxetine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000973	0.000973	CcSEcCtD
Duloxetine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000973	0.000973	CcSEcCtD
Duloxetine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000968	0.000968	CcSEcCtD
Duloxetine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000965	0.000965	CcSEcCtD
Duloxetine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000965	0.000965	CcSEcCtD
Duloxetine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000963	0.000963	CcSEcCtD
Duloxetine—Oedema—Prednisone—ankylosing spondylitis	0.000962	0.000962	CcSEcCtD
Duloxetine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000962	0.000962	CcSEcCtD
Duloxetine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000961	0.000961	CcSEcCtD
Duloxetine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000961	0.000961	CcSEcCtD
Duloxetine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000961	0.000961	CcSEcCtD
Duloxetine—Infection—Prednisone—ankylosing spondylitis	0.000956	0.000956	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000954	0.000954	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000954	0.000954	CcSEcCtD
Duloxetine—Back pain—Methotrexate—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Duloxetine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Duloxetine—Fatigue—Betamethasone—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Duloxetine—Shock—Prednisone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Duloxetine—Pain—Dexamethasone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Duloxetine—Pain—Betamethasone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Duloxetine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000944	0.000944	CcSEcCtD
Duloxetine—Tachycardia—Prednisone—ankylosing spondylitis	0.000939	0.000939	CcSEcCtD
Duloxetine—Skin disorder—Prednisone—ankylosing spondylitis	0.000935	0.000935	CcSEcCtD
Duloxetine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00093	0.00093	CcSEcCtD
Duloxetine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000929	0.000929	CcSEcCtD
Duloxetine—Anorexia—Prednisone—ankylosing spondylitis	0.000917	0.000917	CcSEcCtD
Duloxetine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000914	0.000914	CcSEcCtD
Duloxetine—Anaemia—Methotrexate—ankylosing spondylitis	0.000911	0.000911	CcSEcCtD
Duloxetine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000911	0.000911	CcSEcCtD
Duloxetine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000911	0.000911	CcSEcCtD
Duloxetine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000904	0.000904	CcSEcCtD
Duloxetine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000904	0.000904	CcSEcCtD
Duloxetine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000897	0.000897	CcSEcCtD
Duloxetine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000895	0.000895	CcSEcCtD
Duloxetine—Malaise—Methotrexate—ankylosing spondylitis	0.000889	0.000889	CcSEcCtD
Duloxetine—Vertigo—Methotrexate—ankylosing spondylitis	0.000885	0.000885	CcSEcCtD
Duloxetine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000882	0.000882	CcSEcCtD
Duloxetine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000878	0.000878	CcSEcCtD
Duloxetine—Urticaria—Betamethasone—ankylosing spondylitis	0.000878	0.000878	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000877	0.000877	CcSEcCtD
Duloxetine—Dizziness—Prednisolone—ankylosing spondylitis	0.000876	0.000876	CcSEcCtD
Duloxetine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000874	0.000874	CcSEcCtD
Duloxetine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000874	0.000874	CcSEcCtD
Duloxetine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000874	0.000874	CcSEcCtD
Duloxetine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000874	0.000874	CcSEcCtD
Duloxetine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000874	0.000874	CcSEcCtD
Duloxetine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000872	0.000872	CcSEcCtD
Duloxetine—Insomnia—Prednisone—ankylosing spondylitis	0.00087	0.00087	CcSEcCtD
Duloxetine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000864	0.000864	CcSEcCtD
Duloxetine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000862	0.000862	CcSEcCtD
Duloxetine—Cough—Methotrexate—ankylosing spondylitis	0.00086	0.00086	CcSEcCtD
Duloxetine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00086	0.00086	CcSEcCtD
Duloxetine—Convulsion—Methotrexate—ankylosing spondylitis	0.000854	0.000854	CcSEcCtD
Duloxetine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000847	0.000847	CcSEcCtD
Duloxetine—Myalgia—Methotrexate—ankylosing spondylitis	0.000839	0.000839	CcSEcCtD
Duloxetine—Chest pain—Methotrexate—ankylosing spondylitis	0.000839	0.000839	CcSEcCtD
Duloxetine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000839	0.000839	CcSEcCtD
Duloxetine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000837	0.000837	CcSEcCtD
Duloxetine—Rash—Prednisolone—ankylosing spondylitis	0.000835	0.000835	CcSEcCtD
Duloxetine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000834	0.000834	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000833	0.000833	CcSEcCtD
Duloxetine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000831	0.000831	CcSEcCtD
Duloxetine—Fatigue—Prednisone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Duloxetine—Headache—Prednisolone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Duloxetine—Discomfort—Methotrexate—ankylosing spondylitis	0.000829	0.000829	CcSEcCtD
Duloxetine—Constipation—Prednisone—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Duloxetine—Confusional state—Methotrexate—ankylosing spondylitis	0.000811	0.000811	CcSEcCtD
Duloxetine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000805	0.000805	CcSEcCtD
Duloxetine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000804	0.000804	CcSEcCtD
Duloxetine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000804	0.000804	CcSEcCtD
Duloxetine—Infection—Methotrexate—ankylosing spondylitis	0.000799	0.000799	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000793	0.000793	CcSEcCtD
Duloxetine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000793	0.000793	CcSEcCtD
Duloxetine—Asthenia—Betamethasone—ankylosing spondylitis	0.000793	0.000793	CcSEcCtD
Duloxetine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000789	0.000789	CcSEcCtD
Duloxetine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000787	0.000787	CcSEcCtD
Duloxetine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000787	0.000787	CcSEcCtD
Duloxetine—Nausea—Prednisolone—ankylosing spondylitis	0.000787	0.000787	CcSEcCtD
Duloxetine—Pruritus—Betamethasone—ankylosing spondylitis	0.000782	0.000782	CcSEcCtD
Duloxetine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000782	0.000782	CcSEcCtD
Duloxetine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000781	0.000781	CcSEcCtD
Duloxetine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000778	0.000778	CcSEcCtD
Duloxetine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000774	0.000774	CcSEcCtD
Duloxetine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000773	0.000773	CcSEcCtD
Duloxetine—Rash—Triamcinolone—ankylosing spondylitis	0.000768	0.000768	CcSEcCtD
Duloxetine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000767	0.000767	CcSEcCtD
Duloxetine—Anorexia—Methotrexate—ankylosing spondylitis	0.000767	0.000767	CcSEcCtD
Duloxetine—Rash—Methylprednisolone—ankylosing spondylitis	0.000766	0.000766	CcSEcCtD
Duloxetine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000765	0.000765	CcSEcCtD
Duloxetine—Urticaria—Prednisone—ankylosing spondylitis	0.000765	0.000765	CcSEcCtD
Duloxetine—Headache—Triamcinolone—ankylosing spondylitis	0.000763	0.000763	CcSEcCtD
Duloxetine—Headache—Methylprednisolone—ankylosing spondylitis	0.000761	0.000761	CcSEcCtD
Duloxetine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000761	0.000761	CcSEcCtD
Duloxetine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000761	0.000761	CcSEcCtD
Duloxetine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Duloxetine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000733	0.000733	CcSEcCtD
Duloxetine—Dizziness—Betamethasone—ankylosing spondylitis	0.000731	0.000731	CcSEcCtD
Duloxetine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000731	0.000731	CcSEcCtD
Duloxetine—Insomnia—Methotrexate—ankylosing spondylitis	0.000727	0.000727	CcSEcCtD
Duloxetine—Nausea—Triamcinolone—ankylosing spondylitis	0.000723	0.000723	CcSEcCtD
Duloxetine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000722	0.000722	CcSEcCtD
Duloxetine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000722	0.000722	CcSEcCtD
Duloxetine—Somnolence—Methotrexate—ankylosing spondylitis	0.000715	0.000715	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000709	0.000709	CcSEcCtD
Duloxetine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000708	0.000708	CcSEcCtD
Duloxetine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000703	0.000703	CcSEcCtD
Duloxetine—Vomiting—Betamethasone—ankylosing spondylitis	0.000703	0.000703	CcSEcCtD
Duloxetine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000699	0.000699	CcSEcCtD
Duloxetine—Rash—Betamethasone—ankylosing spondylitis	0.000697	0.000697	CcSEcCtD
Duloxetine—Rash—Dexamethasone—ankylosing spondylitis	0.000697	0.000697	CcSEcCtD
Duloxetine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000696	0.000696	CcSEcCtD
Duloxetine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000696	0.000696	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000694	0.000694	CcSEcCtD
Duloxetine—Fatigue—Methotrexate—ankylosing spondylitis	0.000693	0.000693	CcSEcCtD
Duloxetine—Headache—Dexamethasone—ankylosing spondylitis	0.000692	0.000692	CcSEcCtD
Duloxetine—Headache—Betamethasone—ankylosing spondylitis	0.000692	0.000692	CcSEcCtD
Duloxetine—Asthenia—Prednisone—ankylosing spondylitis	0.00069	0.00069	CcSEcCtD
Duloxetine—Pain—Methotrexate—ankylosing spondylitis	0.000688	0.000688	CcSEcCtD
Duloxetine—Pruritus—Prednisone—ankylosing spondylitis	0.000681	0.000681	CcSEcCtD
Duloxetine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000663	0.000663	CcSEcCtD
Duloxetine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000658	0.000658	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000658	0.000658	CcSEcCtD
Duloxetine—Nausea—Dexamethasone—ankylosing spondylitis	0.000656	0.000656	CcSEcCtD
Duloxetine—Nausea—Betamethasone—ankylosing spondylitis	0.000656	0.000656	CcSEcCtD
Duloxetine—Urticaria—Methotrexate—ankylosing spondylitis	0.000639	0.000639	CcSEcCtD
Duloxetine—Dizziness—Prednisone—ankylosing spondylitis	0.000636	0.000636	CcSEcCtD
Duloxetine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000636	0.000636	CcSEcCtD
Duloxetine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000636	0.000636	CcSEcCtD
Duloxetine—Vomiting—Prednisone—ankylosing spondylitis	0.000612	0.000612	CcSEcCtD
Duloxetine—Rash—Prednisone—ankylosing spondylitis	0.000607	0.000607	CcSEcCtD
Duloxetine—Dermatitis—Prednisone—ankylosing spondylitis	0.000606	0.000606	CcSEcCtD
Duloxetine—Headache—Prednisone—ankylosing spondylitis	0.000603	0.000603	CcSEcCtD
Duloxetine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000593	0.000593	CcSEcCtD
Duloxetine—Asthenia—Methotrexate—ankylosing spondylitis	0.000577	0.000577	CcSEcCtD
Duloxetine—Nausea—Prednisone—ankylosing spondylitis	0.000572	0.000572	CcSEcCtD
Duloxetine—Pruritus—Methotrexate—ankylosing spondylitis	0.000569	0.000569	CcSEcCtD
Duloxetine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00055	0.00055	CcSEcCtD
Duloxetine—Dizziness—Methotrexate—ankylosing spondylitis	0.000532	0.000532	CcSEcCtD
Duloxetine—Vomiting—Methotrexate—ankylosing spondylitis	0.000511	0.000511	CcSEcCtD
Duloxetine—Rash—Methotrexate—ankylosing spondylitis	0.000507	0.000507	CcSEcCtD
Duloxetine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000507	0.000507	CcSEcCtD
Duloxetine—Headache—Methotrexate—ankylosing spondylitis	0.000504	0.000504	CcSEcCtD
Duloxetine—Nausea—Methotrexate—ankylosing spondylitis	0.000478	0.000478	CcSEcCtD
